Antonella Antignani

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Managing the TME to improve the efficacy of cancer therapy”.

Managing the TME to improve the efficacy of cancer therapy

Frontiers in Immunology(2022)10.3389/fimmu.2022.954992

N/A

0DataRank · unranked

298 citations

Antonella Antignani, David Fitzgerald, Maria Teresa Bilotta

Antibody drug conjugates, targeting cancer-expressed EGFR, exhibit potent and specific antitumor activity

Biomedicine & Pharmacotherapy(2022)10.1016/j.biopha.2022.114047

N/A

0DataRank · unranked

14 citations

Rong Qiu, Ellis Miller, Maria Teresa Bilotta, David Fitzgerald, Antonella Antignani +1 more

Birinapant selectively enhances immunotoxin‐mediated killing of cancer cells conditional on the IAP protein levels within target cells

The FASEB Journal(2023)10.1096/fj.202301052r

N/A

0DataRank · unranked

1 citations

Maria Teresa Bilotta, Jacob S. Roth, Daniel J. Urban, Min Shen, Matthew D. Hall +2 more